Lonza subsidiaries Lonza Ltd and Lonza Inc say they have settled their recently filed patent and trademark infringement action against raw materials supplier DNP International in the District Court for the Central District of California.
DNP has agreed to refrain from infringing the Lonza patents relating to the use of L-carnitine in swine, poultry and racing animals and Lonza's registeredtrademark CARNIKING, according to the Swiss company. DNP also made a monetary payment to Lonza and agreed to the entry of a consent judgment and order to resolve the matter, said Lonza. The exact terms of the settlement were not revealed.
Headquartered in Basel, Switzerland, Lonza has established itself as one of the leading suppliers of L-carnitine to the health industry and has gone to great lengths to develop its patent and trademark portfolio for the nutritionaluses of the nutrient.
In a statement the company said it viewed the suit against DNP and its favorable settlement as a significant step in protecting its intellectual property rights.
Lonza, which had sales of SF2.54 billion in 2002, did not release information on other actions taken against supplement companies Carnitech, Barrington, Stauber and Axel Chemical, filed at the same time as the DNP suit.